By: Benzinga
UPDATE: Citigroup Initiates Maximus at Buy on Health Care Reform Opportunities
Citigroup initiated coverage on Maximus (NYSE: MMS ) with a Buy rating and a $75 price target. Citigroup said, "Over the next three years, we think Maximus can more than double earnings. The company will continue to benefit from states moving fee for service Medicaid programs over to managed
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here